2. Produce and review information to estimate the national burden of disease associated with hepatitis A and direct use of hepatitis A vaccine in immunization services. This may require examining vital registration systems, acute disease surveillance, surveys estimating age-specific prevalence of antibodies and health information systems capturing fulminant disease and /or causes of liver transplantation. Economic evaluation can serve as a useful additional element for decision-making.